-
Cost-Effectiveness Analysis of Sunvozertinib as a Second-line Treatment for Advanced Non-Small Cell Lung Cancer with EGFR exon20ins Mutation: An Economic Evaluation Based on MAIC
Mar 10, 2025, 14:00 PM -
Measuring and Reporting Health-Related Quality of Life (HRQoL) in Locally Advanced/Metastatic Urothelial Cancer (La/mUC) Research: Capturing Outcomes That Really Matter to Patients
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Olaparib and Niraparib With Abiraterone Versus Abiraterone for First-Line Treatment of BRCA Mutated Metastatic Castration-Resistant Prostate Cancer in Taiwan
Mar 10, 2025, 14:00 PM -
Marginal Healthcare Expenditure Burden of Patients With Substance Use Disorder In The United States
Mar 10, 2025, 14:00 PM -
Eosinophilic Esophagitis-Related Healthcare Resource Utilization and Associated Costs for Payers and Patients: A Retrospective Cohort Study of US Health Insurance Claims Data
Mar 10, 2025, 14:00 PM -
Avoidable Costs by the Inclusion Ff Finerenone in Terms of Hospitalization Due to Heart Failure (HF) and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia
Mar 10, 2025, 14:00 PM -
Revolutionizing Multi-Level Network Meta-Regression: Advancing Analysis With the Package
Mar 10, 2025, 14:00 PM -
A Retrospective Real-World Data Analysis of Pregnancy Outcomes Among Women with a History of Hysteroscopic Intrauterine Adhesiolysis (HA), Other Intrauterine Surgery (IUs), or no Prior IUs
Mar 10, 2025, 14:00 PM -
Socio-Economic and Behavioural Impacts of COVID-19 Vaccine Mandates: A Scoping Review
Mar 10, 2025, 14:00 PM -
AMCP Dossier v5.0: U.S. Payer Preferences and Utilization to Support Formulary Decision Making
Mar 10, 2025, 14:00 PM -
Optimizing Adherence to Intravenous Iron: A Geographic Analysis of Variability Within the United States
Mar 10, 2025, 14:00 PM -
Real-World Health-Related Quality of Life and Treatment Satisfaction in Patients With High-Risk Non-Muscle Invasive Bladder Cancer
Mar 10, 2025, 14:00 PM -
An Analysis of Hospitalization Metrics After Intravenous (IV) Ferric Derisomaltose (FDI) versus Usual Care (UC) in Patients with Iron Deficiency Anemia (IDA) and Heart Failure (HF) Based on IRONMAN
Mar 10, 2025, 14:00 PM -
Staffing Resource Use: A Cost Impact Model for the Utilization and Implementation of Medications for Opioid Use Disorder Within US Jails And Prisons
Mar 10, 2025, 14:00 PM -
Estimating the Potential Cost-Effectiveness of Long-Acting Naltrexone versus Oral Naltrexone for Alcohol Use Disorder
Mar 10, 2025, 14:00 PM -
Impact of Emicizumab on Quality of Life and Clinical Outcomes in Patients with Hemophilia A in Guatemala
Mar 10, 2025, 14:00 PM -
Is Bayesian Statistics an Emerging Way for Extrapolating Survival in Cost-Effectiveness Analysis: A Systematic Review
Mar 10, 2025, 14:00 PM -
Evaluating the ROI of a Virtual Maternity Care Initiative Across Medicaid Plans in a Single State
Mar 10, 2025, 14:00 PM -
Discordance Between Apolipoprotein B (apoB) and LDL-Cholesterol (LDL-C) and Incident Hypertension Risk among Patients with and without Type 2 Diabetes (T2D): An Analysis of US Real-World Data
Mar 10, 2025, 14:00 PM -
Keeping With the Times: Emerging Methods for More Precise Survival Estimates to Inform Cost-Effectiveness Analysis
Mar 10, 2025, 14:00 PM
